Track the 압타머사이언스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 압타머사이언스 has logged 35 insider filings. The latest transaction was disclosed on 26 November 2025 (Purchase). Among the most active insiders: 류성호. Every trade is free.
35
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Aptamer Science is a company focused on developing aptamer-based therapies for applications in the healthcare and pharmaceutical sector. It is listed on the XKRX market.